Background
Heterogeneity has been noted in the selection and reporting of disease-specific pediatric outcomes in randomized controlled trials (RCTs) [1] . The consequence may be invalid results from RCTs, or difficulty in comparing results across trials [2, 3] . The primary objective of this systematic review was to assess the heterogeneity of outcome measures selection and reporting in recent 
Methods
We searched MEDLINE, EMBASE, The Cochrane Library, Cochrane Central Register of Controlled Trials (CENTRAL), and CINAHL from the last ten years, including randomized controlled trials of EoE treatment in patients 0-18 years. Two authors independently assessed articles for inclusion.
Results
A total of 11 studies met inclusion criteria (Fig 1) . Numerous outcome measures were selected and reported in these trials, with certain measures, such as esophageal eosinophilia, clinical symptoms, safety, histologic features, and endoscopic features, re-occurring frequently, but not universally. Uptake of consensus-established diagnostic criteria for EoE (FIGER criteria) was 30% in trials published after 2007. Due to the small number and heterogeneity of studies obtained, no conclusions regarding treatment efficacy could be made.
Conclusions
The results of this study confirm the need for universally reported, pediatric-specific, standardized outcome measures in EoE trials. Adherence to standardized disease definitions will enhance the utility of outcome measures. Consistent disease definition and standardized outcome reporting will allow for meta-analyses across similar trials and thus inform future clinical decision-making in pediatric EoE.
